PhenomeX Inc. Common Stock
CELL
CELL was delisted on the 29th of September, 2023.
132 hedge funds and large institutions have $899M invested in PhenomeX Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 46 increasing their positions, 39 reducing their positions, and 30 closing their positions.
18% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 39
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 137 → 132 (-5)
6% less capital invested
Capital invested by funds: $954M → $899M (-$54.8M)
13% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 30
31% less call options, than puts
Call options by funds: $4.86M | Put options by funds: $7.04M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$28.5M |
| 2 |
BlackRock
New York
|
+$18M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$17M |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$16.6M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$8.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SUT
SC US (TTGP)
Menlo Park,
California
|
-$25.2M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$14.5M |
| 3 |
THP
Tower House Partners
London,
United Kingdom
|
-$11.7M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11.4M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$10.7M |
CELL Hedge Fund Activity: Q4 2021 in Review
132 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in PhenomeX Inc. Common Stock (CELL) for Q4 2021, worth a combined $899M — down 5.7% from $954M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of CELL and 26 opened new positions — a net loss of 4 holders — while 39 trimmed existing stakes and 46 added.
The largest buyer was Invesco, adding an estimated $28.5M. The largest seller was SC US (TTGP), cutting an estimated $25.2M.
- 132 institutional investors held PhenomeX Inc. Common Stock (CELL) as of Q4 2021, down from 137 in Q3 2021.
- Funds reported $899M of PhenomeX Inc. Common Stock stock for Q4 2021, down 5.7% quarter-over-quarter.
- 26 funds opened new PhenomeX Inc. Common Stock positions in Q4 2021 and 30 closed out, a net change of -4 holders.
- The largest PhenomeX Inc. Common Stock buyer in Q4 2021 was Invesco, an estimated $28.5M added.
- The largest PhenomeX Inc. Common Stock seller in Q4 2021 was SC US (TTGP), an estimated $25.2M sold.
Based on aggregated 13F filings for Q4 2021.